TNFA - TNF Pharma Kapitalizatsiyaning sotish hajmiga nisbati

TNF Pharmaceuticals (TNFA) tovar belgisi

TNF Pharmaceuticals sog'liqni saqlash gigantining o'simta nekroz omilini o'rganishga asoslangan maqsadli terapiya ekotizimi joriy tendentsiyani belgilaydi, bunda kompaniyaning narx/savdo ko'rsatkichi uning bozor qiymatini tasdiqlaydi. ko'rsatkichi yangi klinik sinov natijalari kutilayotgan davrdagi metrikaning holatini ifodalaydi. Noyob patentlar va qat'iy FDA nazorati himoya aktivlari vazifasini bajarib, raqobatchilar uchun kirishning yuqori to'siqlarini yaratadi.

TNFA (tnfpharma.com) P/S multiplikatori tarixi 04.07.2022dan 13.11.2026gacha

TNF Pharmaceuticals (TNFA) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi tnfpharma.com|TNFA - Konsensus maqsadli narx
- bozor kapitallashuvi statistikasi:
Bozor qiymati TNF Pharma|TNFA - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga xususiy kapital TNF Pharmaceuticals|TNFA - Balans kapitallashuvi|Sof aktivlarga nisbatan bozor kapitallashuvi tnfpharma.com|TNFA - Kompaniyaning yakuniy aktivlari
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati TNF Pharmaceuticals|TNFA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati tnfpharma.com|TNFA - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati TNF Pharma|TNFA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari TNF Pharmaceuticals|Oraliq qoplash koeffitsiyenti tnfpharma.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
TNFA - Kompaniyaning sof foydasi|Kelajakdagi foyda TNF Pharmaceuticals|TNFA - P/E multiplikatori|Forvard P/E multiplikatori tnfpharma.com|TNFA - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti TNF Pharma|TNFA - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda TNF Pharmaceuticals|TNFA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi tnfpharma.com|TNFA - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi TNF Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
TNFA - Daromad va sotish hajmi|Kompaniyaning kelajakdagi savdosi tnfpharma.com|TNFA - P/S multiplikatori|Forvard narx/daromad multiplikatori TNF Pharma
Kompaniyaning umumiy tahlili:TNF Pharmaceuticals Inc., TNFA
TNF Pharmaceuticals tayyor mahsulotlari

P/S koeffitsienti TNF Pharmaceuticals (TNFA) kompaniyasining bozor qiymatini uning yillik daromadiga nisbatan aniqlaydi va bu operatsion xarajatlarni hisobga olmagan holda aktivlarning monetizatsiya qilish samaradorligini baholash imkonini beradi. Zavodlarning ekologik modernizatsiyasi va suv iste'molining yopiq siklli tizimlariga kiritilgan investitsiyalar vaqtincha marjalarga ta'sir qilishi mumkin; shuning uchun, texnologik yangilanish davrlarida savdo hajmidagi narx koeffitsienti biznesning fundamental haddan tashqari baholanganligining asosiy ko'rsatkichi bo'lib xizmat qiladi.

Raqobatdosh kompaniyalar

HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|Kenvue - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati VRNA (Verona Pharma PLC)|MENS - Narxning daromadga nisbati|LGND (Ligand Corp) - Kapitalizatsiya va daromad nisbati|AMRX: P/S multiplikatori|Narxning sotuvga nisbati PRGO (perrigo.com)|Kapitalizatsiyaning daromadga nisbati ALVO|LQDA: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Galapagos Genomics (GLPG)|ANIP: Narxning sotuvga nisbati|P/S multiplikatori MNKD (MannKind Corporation)|Bozor kapitallashuvining daromadga nisbati AMPH|Pacira BioSciences, Inc. - P/S multiplikatori|SPRY - P/S multiplikatori|Theravance (TBPH) - Narxning daromadga nisbati|Aquestive Corp - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati scPharmaceuticals, Inc.|Kapitalizatsiyaning daromadga nisbati Tectonic (TECX)|P/S multiplikatori TNXP|P/S multiplikatori sxtchina.com (SXTC)|P/S multiplikatori EPRX (Eupraxia Pharmaceuticals Inc.)|BHST - Kapitalizatsiyaning daromadga nisbati|eXoZymes Inc - P/S multiplikatori|Sotuvga nisbatan narx Oramed Pharmaceuticals|ENTX (enterabio.com) - Kapitalizatsiyaning daromadga nisbati|MindWalk Holdings, Inc. (HYFT) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati ABVC|CPIX (Cumberland Corp) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori QNTM|Narx/daromad koeffitsiyenti fibrogen.com|P/S multiplikatori TELO (Telomir Pharmaceuticals, Inc.)|RANI - Kapitalizatsiyaning daromadga nisbati|Synergy CHC Corporation - P/S multiplikatori|RLYB - P/S multiplikatori|lexariabioscience.com (LEXX) - Narxning daromadga nisbati|PULM (pulmatrix.com) - Narxning daromadga nisbati|Narxning daromadga nisbati Pheton Holdings Limited|Aptorum (APM) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati LYRA (Lyra Therapeutics, Inc)|Kapitalizatsiyaning sotish hajmiga nisbati IBO|Narxning daromadga nisbati cbdMD YCBD|PRFX: Kapitalizatsiya va daromad nisbati|Auris Medical - P/S multiplikatori|Narxning sotuvga nisbati LIPO|OPTN: P/S multiplikatori|Pieris Pharma (PIRS) - P/S multiplikatori|Narxning daromadga nisbati Procaps Group S.A.|petrospharma.com - Narxning sotuvga nisbati|P/S multiplikatori QLI|SLRN (Acelyrin Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori TFFP (TFF Pharma)